Press Releases
Lannett Receives Approval For Niacin Extended-Release Tablets USP, 500 Mg And 1000 Mg
Lannett Company Inc announced that it received approval from the U.S. FDA of its Abbreviated New Drug Application (ANDA) for Niacin Extended-Release Tablets USP,...
Press Releases
TraceLink Expands European Headquarters to Accommodate Projected 207% EU Employee Growth in 2017
TraceLink Inc., the World’s Largest Track and Trace Network for connecting the life sciences supply chain and providing real-time information sharing for better patient...
News
Greenphire Continues Commitment to CRO Empowerment with New Payments Advisory Group
Greenphire, the global leader in clinical trial payment automation, has established an Advisory Group for the growing CRO community. The goal of this group...
Industry Reports
Eurofins expands its leadership in biopharmaceutical services with the acquisition of Alphora Research Inc
Eurofins Scientific , a world leader in biopharmaceutical testing, announces the acquisition of Alphora Research Inc , a full service contract research, development and...
Drug Research
Numerate and Takeda Enter Agreement to Generate Novel Clinical Candidates Using AI-Driven Drug Discovery
Numerate, Inc., a computational drug design company applying artificial intelligence (AI) at cloud scale to transform small molecule drug discovery, announced the formation of...
Articles
Examining the operational challenges presented by serialisation
The deadlines for serialisation compliance in the EU and the U.S. are drawing closer. For many pharmaceutical companies, the journey towards implementing a full...
Clinical Trials
Astellas and Pfizer Announce Amendment to Clinical Research Protocol for Phase 3 PROSPER Trial of enzalutamide
Astellas Pharma Inc and Pfizer Inc announced the amendment of the protocol for the registrational PROSPER trial, a multi-national, randomized, double-blind, placebo-controlled study evaluating...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read